FDA Approves Toxic Remdesivir for Babies

Remember the drug that was dropped from the Ebola treatment trial because Ebola patients died faster on it? Yeah, that drug.

The FDA has expanded approval of the remdesivir to treat Covid-19 patients as young as 28 days and weighing about 7 pounds.

Sam 🌸 @sammyfran2

FDA approves Remdesivir for babies, 28 days old +. The insanity never seems to end. Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children

fda.govCoronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young ChildrenToday, the FDA approved the first COVID-19 treatment for children less than 12 years of age.

Yes, this remdesivir…

⚡️THOR⚡️ the Deplorable 🇺🇸 @ThorDeplorable

Remdesivir.

“If you look at the four independent studies, including the large study by the WHO, it shows… remdesivir increases the risk of death. Let me say that again. Remdesivir increases the risk of death by 3%. It increases your risk of renal failure by 20%. This is a toxic drug.

But just to make the situation even more preposterous, the federal government will give hospitals a 20% bonus on the entire hospital bill if they prescribe remdesivir to medicare patients. The federal government is incentivizing hospitals to prescribe a medication that is toxic.”

And this remdesivir…

M. Todd Trebony, MD FAAC @doc_singing

In the Ebola trial, 54% PERCENT of the Remdesivir treated subjects, DIED! Fauci broke the blind and stopped the trial. When you remove your placebo group, you disguise and hide the poor safety profile. He then went on to hand the drug over to Gilead, for them to make billions.

According to an FDA press release, approval is based in part on results from a phase 3 clinical trial for adults.

Given the similar course of COVID-19 disease in adults and pediatric patients, today’s approval of Veklury in certain pediatric patients is supported by efficacy results from phase 3 clinical trials in adults.

Additionally, a clinical study of 53 pediatric patients demonstrated that “the safety and pharmacokinetic results from the phase 2/3 study in pediatric subjects were similar to those in adults.” I don’t have access to those results, but this is NOT reassuring.

The drug has been approved for children 4 weeks and up who are either hospitalized or “at high risk for progression to severe COVID-19,” but what does it mean to be at high risk? Regulatory authorities repeatedly claim that “COVID-19 can cause severe illness in children, some of whom do not currently have a vaccination option.”

Will unvaccinated children (currently all children under 5) be considered “high risk”?

This would be a good time to remember that children have virtually zero risk of serious complications from COVID and almost zero healthy children die from it.

If children experience similar results as adults, CHILDREN WILL DIE.

Sadly, these deaths will in all likelihood be deemed “COVID deaths.” Those deaths will contribute to scarier numbers. Those inflated numbers will inevitably be used to try and justify Emergency Use Authorization of pediatric COVID shots that have repeatedly performed poorly in clinical trials.

BREAKING: the Pfizer clinical trial in kids under age 5 has now failed TWICE

BREAKING NEWS: Three sources tell Politico that Pfizer's EUA application to inject kids under 5 pushed back to June

And should we stop and consider the potential repercussions of anti-viral resistant mutations of COVID?

Am I selfish again for thinking our kids deserve way better?